COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • September 11th, 2017 • Innovation Pharmaceuticals Inc. • Pharmaceutical preparations • Nevada
This COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), is dated as of September 6, 2017 by and between INNOVATION PHARMACEUTICALS INC., a Nevada corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 11th, 2017 • Innovation Pharmaceuticals Inc. • Pharmaceutical preparations • Nevada
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 6, 2017, by and between INNOVATION PHARAMCEUTICALS INC., a Nevada corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
Form of Stock Option Award AgreementStock Option Award Agreement • September 11th, 2017 • Innovation Pharmaceuticals Inc. • Pharmaceutical preparations • Nevada
This Stock Option Award Agreement (this “Agreement”) is effective as of ______________ by and between Innovation Pharmaceuticals Inc., a Nevada corporation (f/k/a Cellceutix Corporation) (the “Company”) and _________________ (the “Holder”).
